Prevalence and genotype distribution of human papillomavirus infections among women undergoing HPV testing during 2019–2024 in Xi’an, China
6 affiliations
- 1Department of Clinical Laboratory, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710004 China
- 2National-Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710004 China
- 3Core Research Laboratory, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710004 China
- 4Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710004 China
- 5Key Laboratory of Surgical Critical Care and Life Support (Xi’an Jiaotong University), Ministry of Education, Xi’an, 710004 China
- 6The Second Affiliated Hospital of Xi’an Jiaotong University, 157 West Fifth Road, Xi’an, 710004 China
Abstract
Background: Human papillomavirus (HPV) persistent infection is the primary cause of cervical cancer, with significant regional variations in infection prevalence and genotype distribution. This study aimed to clarify the epidemiological characteristics of HPV infection among women in Xi’an from April 2019 to December 2024, and to provide targeted evidence for local cervical cancer screening and prevention strategies.
Methods: A retrospective analysis was conducted on 33,316 women (aged ≥ 20 years) who underwent HPV testing at the Second Affiliated Hospital of Xi’an Jiaotong University during the study period, with repeated tests from the same individual excluded. PCR-reverse dot blot hybridization was used to detect 28 HPV genotypes. The chi-square test was applied for intergroup comparison of infection rates, with P < 0.05 considered statistically significant. Statistical analysis was performed using SPSS 23.0, and graphs were generated with GraphPad Prism 9.0.
Results: The overall HPV positivity rate was 13.96% (4,650/33,316), with single-type infections accounting for 74.67% (3,472/4,650) and multiple-type infections for 25.33% (1,178/4,650). The top three prevalent genotypes were HPV52 (18.00%), HPV53 (12.19%), and HPV16 (9.23%). Significant differences in HPV infection rates were observed among health examination population (12.67%), inpatients (20.85%) and outpatients (37.68%) (P < 0.001), as well as across different age groups (P < 0.001), with the highest infection rate in the 61–70 years group. The overall HPV infection rate showed a fluctuating upward trend from 2019 (11.52%) to 2024 (19.94%), with high-risk HPV (HR-HPV) infection rate increasing from 7.72% to 15.58% over the same period.
Conclusions: Single-type HPV infection is the main type of infection among women in Xi’an, with HPV52, HPV53 and HPV16 being the dominant genotypes. Infection rates vary significantly by patient source and age, with older women aged 61–70 years at the highest risk of infection. These findings highlight the need to optimize local cervical cancer screening strategies, strengthen HPV vaccination for young women, and conduct regular regional HPV epidemiological surveillance.
Related
- An 11-Year Comprehensive Retrospective Study on the Prevalence and Genotype Distribution of Human Papillomavirus (HPV) in Women and Men in Türkiye and Northern Cyprus
- Prevalence, genotype distribution and associated factors of high-risk human papillomavirus among pregnant women in Eastern Ethiopia: a cross-sectional analysis nested within a population-based cohort study
- Prevalence and genotype distribution of human papillomavirus among 15,224 gynecological outpatients in Xuzhou, China, during 2023-2025.
- Prevalence and genotype distribution of human papillomavirus (HPV) among adolescent girls and young women in a high HIV burden rural area of South Africa: a cross-sectional survey
- Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria
BibTeX
@article{xu2026prevalence,
title = {{Prevalence and genotype distribution of human papillomavirus infections among women undergoing HPV testing during 2019–2024 in Xi’an, China}},
author = {Nan Xu and Li Jin and Burong Li and Yue Zhang and Hua Zhang and Jia Song and Yuqi Zhao and Zhe An and Guodong Li and Xiaoqin Hu and Yanping Zhang and Lun Huang and Weiwei Zhang and Yan Geng and Jianhong Zhu and Fang Huang and Qian He and Bo Cao and Li Xue},
journal = {BMC Infectious Diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-14232-3},
url = {https://doi.org/10.1186/s12879-026-14232-3},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prevalence and genotype distribution of human papillomavirus infections among women undergoing HPV testing during 2019–2024 in Xi’an, China
AU - Nan Xu
AU - Li Jin
AU - Burong Li
AU - Yue Zhang
AU - Hua Zhang
AU - Jia Song
AU - Yuqi Zhao
AU - Zhe An
AU - Guodong Li
AU - Xiaoqin Hu
AU - Yanping Zhang
AU - Lun Huang
AU - Weiwei Zhang
AU - Yan Geng
AU - Jianhong Zhu
AU - Fang Huang
AU - Qian He
AU - Bo Cao
AU - Li Xue
PY - 2026
DA - 2026/08/14
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-14232-3
UR - https://doi.org/10.1186/s12879-026-14232-3
AB - Background: Human papillomavirus (HPV) persistent infection is the primary cause of cervical cancer, with significant regional variations in infection prevalence and genotype distribution. This study aimed to clarify the epidemiological characteristics of HPV infection among women in Xi’an from April 2019 to December 2024, and to provide targeted evidence for local cervical cancer screening and prevention strategies. Methods: A retrospective analysis was conducted on 33,316 women (aged ≥ 20 years) who underwent HPV testing at the Second Affiliated Hospital of Xi’an Jiaotong University during the study period, with repeated tests from the same individual excluded. PCR-reverse dot blot hybridization was used to detect 28 HPV genotypes. The chi-square test was applied for intergroup comparison of infection rates, with P < 0.05 considered statistically significant. Statistical analysis was performed using SPSS 23.0, and graphs were generated with GraphPad Prism 9.0. Results: The overall HPV positivity rate was 13.96% (4,650/33,316), with single-type infections accounting for 74.67% (3,472/4,650) and multiple-type infections for 25.33% (1,178/4,650). The top three prevalent genotypes were HPV52 (18.00%), HPV53 (12.19%), and HPV16 (9.23%). Significant differences in HPV infection rates were observed among health examination population (12.67%), inpatients (20.85%) and outpatients (37.68%) (P < 0.001), as well as across different age groups (P < 0.001), with the highest infection rate in the 61–70 years group. The overall HPV infection rate showed a fluctuating upward trend from 2019 (11.52%) to 2024 (19.94%), with high-risk HPV (HR-HPV) infection rate increasing from 7.72% to 15.58% over the same period. Conclusions: Single-type HPV infection is the main type of infection among women in Xi’an, with HPV52, HPV53 and HPV16 being the dominant genotypes. Infection rates vary significantly by patient source and age, with older women aged 61–70 years at the highest risk of infection. These findings highlight the need to optimize local cervical cancer screening strategies, strengthen HPV vaccination for young women, and conduct regular regional HPV epidemiological surveillance.
SN - 1471-2334
ER -